Inventor
Paula S. Hochman
Inventor
Newton, MA, US
Overview
Patents· 18 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
A61KPreparations for medical, dental or toiletry purposes23%
C07KPeptides19%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests14%
Y02ATechnologies for adaptation to climate change11%
G01NInvestigating or analysing materials by determining their chemical or physical properties5%
PatentTitleYear
10,302,654Anti-VLA-4 related assays20199,726,672'Anti-VLA-4 related assays'20179,377,458'Anti-VLA-4 related assays'20169,314,534'Polymer conjugates of interferon beta-1A and uses'20168,455,445'Methods for inhibiting lymphotoxin-β receptor signaling in TH1 cell-associated disorders'20138,287,874'Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases'20127,951,371'Soluble lymphotoxin-β receptor fusion protein and methods for inhibiting lymphotoxin β-receptor signaling'20117,744,891'Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases'20107,527,946'Interferon-beta-1a-immunoglobulin fusion proteins and uses'20097,446,173'Polymer conjugates of interferon beta-1A and uses'20087,427,403'Methods for inhibiting lymphotoxin β receptor signalling'20087,309,492'Soluble lymphotoxin-β receptors as therapeutic agents for the treatment of systemic lupus erythematosus'20077,255,854'Use of lymphotoxin-β receptor blocking agents for the treatment of antibody mediated immunological diseases'20076,962,978'Polymer conjugates of interferon beta-1a and uses'20056,800,735'Interferon-beta fusion proteins and uses'20046,669,941'Soluble lymphotoxin- receptor as a therapeutic agent for treating TH-1 cell-associated autoimmune disease'20036,403,087'Soluble lymphotoxin- receptors as therapeutic agents for the treatment of immunological disease'20025,925,351'Soluble lymphotoxin-.beta. receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease'1999Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1999–2007Patents assigned to BIOGEN INC (5)· patent assignee history
1999–2012Based in Brookline, MA, US· patent location history
2002–2019Based in Newton, MA, US· patent location history
2004–2013Patents assigned to BIOGEN IDEC INC (9)· patent assignee history
2007Based in Newtown, MA, US· patent location history
2012–2016Patents assigned to HOCHMAN PAULA S (3)· patent assignee history
2012–2013Patents assigned to BROWNING JEFFREY L (2)· patent assignee history
2016–2019Patents assigned to BIOGEN MA INC (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BIOGEN IDEC INC | 9 | 2004–2013 |
| BIOGEN INC | 5 | 1999–2007 |
| BIOGEN MA INC | 4 | 2016–2019 |
| HOCHMAN PAULA Sself | 3 | 2012–2016 |
| BROWNING JEFFREY L | 2 | 2012–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Newton, Massachusetts, US | 12 | 2002–2019 |
| Brookline, Massachusetts, US | 5 | 1999–2012 |
| Newtown, Massachusetts, US | 1 | 2007 |